Scholar Rock Holding Corporation

SRRK Healthcare Biotechnology

Scholar Rock Holding Corporation’s revenue for fiscal 2022 (year ended December 2022) was $33.2 million. In the quarter to June 2026, EPS grew 14.3%, free cash flow grew 8.88% and total debt rose 294.3%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

39.85 0.79 −1.94%
Market cap
$5.0B
P/E
0.0×
Fwd P/E
−7.3×
Dividend yield
—
F-score
3/9
Altman Z
1.14
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
— — — —

+8 more quarters

EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
7.02 8.64 6.95 6.30
Net Debt/EBITDA
2.72 2.78 2.93 2.60
Debt/Equity
0.77 0.71 0.41 0.41
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(0.54) (0.65) (0.66) (0.61)
Book value per Share
1.94 2.17 2.14 2.15
Free Cash Flow
(70.31) (82.17) (75.53) (69.01)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates